Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma Industry Pushes A Broadened Meaning For “Orphan”

Sep 19 2011

• By Shirley Haley

Related Content

Who's Afraid Of Big Pharma? Perhaps The Rare Disease Community

Apr 14 2011

FDA Steps Into Makena Pricing Dispute In The Name Of "Access"

Apr 04 2011

As Pharma Falters, Shire Specialist Model Hits Sweet Spot

Aug 02 2011

CF Patients Breathe Easier With Vertex Drug

Feb 23 2011

Hill Democrats Continue Inquiries Into High Prices For New Versions Of Old Drugs; Avanir's Nuedexta And URL Pharma's Colcrys Targeted

May 25 2011

Pricing Rare Disease Drugs Requires Care As Payers Increase Scrutiny

Aug 29 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window